Home » Topics » BioWorld

BioWorld
RSS

CENTOCOR HALTS TRIALS; STOCK PLUMMETS

Jan. 19, 1993

TLC UNDERWRITERS EXERCISE OPTION

Jan. 18, 1993

EPA PROPOSES REDUCED REGULATIONS FOR FIELD TRIALS

Jan. 18, 1993

FOCAL RAISES $9.2 MILLION IN PRIVATE PLACEMENT

Jan. 18, 1993

NORSK WITHDRAWS FROM DEAL WITH TELIOS

Jan. 18, 1993

EUROPEAN PATENT DISLOSURES

Jan. 18, 1993

CYTRX FORMS SUBSIDIARY

Jan. 18, 1993

MEDCLONE MAB DESIGNATED ORPHAN DRUG

Jan. 18, 1993

FDA OKS UNIVAX VACCINATION PROGRAM

Jan. 18, 1993

BAXTER LICENSES IMMUNE CELL TECHNOLOGY

Jan. 18, 1993

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...